Hansen Donovan, Pollan Lee D, Fernando Hiran
Chief Resident, Division of Oral and Maxillofacial Surgery, Department of Dentistry, University of Rochester Medical Center/Strong Memorial Hospital, Rochester, NY.
J Oral Maxillofac Surg. 2013 Nov;71(11):1880-5. doi: 10.1016/j.joms.2013.04.035. Epub 2013 Jul 17.
Antibiotic prophylaxis for maxillofacial surgical wounds remains common practice. Surgeons must weigh the risks (e.g., Clostridium difficile colitis) against the benefits before administering antibiotics for any reason and the relative risk and morbidity of C difficile colitis against those of a potential postoperative wound infection. In addition, the possibility of C difficile infection as a complication of perioperative antibiotic prophylaxis should be discussed with patients before surgery, especially those with concomitant baseline risk factors. This report describes the case of a young healthy patient with few risk factors for C difficile infection who received a standard perioperative course of antibiotic therapy. Subsequently, the patient developed severe fulminant C difficile infection that required a protracted hospital admission, subtotal colectomy, and ileostomy. This case underscores that antibiotic prophylaxis continues in widespread use and is not benign therapy.
对面部外科伤口进行抗生素预防仍是常见的做法。外科医生在出于任何原因使用抗生素之前,必须权衡风险(如艰难梭菌性结肠炎)与益处,以及艰难梭菌性结肠炎的相对风险和发病率与潜在术后伤口感染的风险和发病率。此外,术前应与患者讨论艰难梭菌感染作为围手术期抗生素预防并发症的可能性,尤其是那些伴有基线风险因素的患者。本报告描述了一名几乎没有艰难梭菌感染风险因素的年轻健康患者,接受了标准的围手术期抗生素治疗疗程。随后,该患者发生了严重的暴发性艰难梭菌感染,需要长期住院、次全结肠切除术和回肠造口术。该病例强调,抗生素预防仍在广泛使用,并非无害治疗。